Kezar Life Sciences Inc. (NASDAQ: KZR)
$0.68
+0.0321 ( +4.94% ) 656.7K
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
Market Data
Open
$0.68
Previous close
$0.65
Volume
656.7K
Market cap
$49.44M
Day range
$0.65 - $0.70
52 week range
$0.54 - $2.55
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Jul 26, 2023 |
| 4 | Insider transactions | 1 | Jul 26, 2023 |
| 4 | Insider transactions | 1 | Jul 26, 2023 |
| 4 | Insider transactions | 1 | Jul 26, 2023 |
| 4 | Insider transactions | 1 | Jul 26, 2023 |
| 4 | Insider transactions | 1 | Jul 26, 2023 |
| 4 | Insider transactions | 1 | Jul 26, 2023 |
| 4 | Insider transactions | 1 | Jul 26, 2023 |
| 4 | Insider transactions | 1 | Jul 26, 2023 |
| 4 | Insider transactions | 1 | Jul 26, 2023 |